Monogenic and other unusual causes of diabetes mellitus

Pediatric Clinics of North America

Volumn 52, Issue 6, 2005, Pages 1637-1650

  Nakhla, Meranda ^a   Polychronakos, Constantin ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; SULFONYLUREA;

CLINICAL FEATURE; CYSTIC FIBROSIS; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MATERNAL DIABETES MELLITUS; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; WOLFRAM SYNDROME;

CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; GLUCOSE; HUMANS; INFANT, NEWBORN; INSULIN; INSULIN-SECRETING CELLS; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; MUTATION; RECEPTOR, INSULIN; WOLFRAM SYNDROME;

EID: 27844608950     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2005.07.005     Document Type: Review

References (54)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 28 Suppl 1 2005 S37 S42
2. S.S. Fajans, G.I. Bell, and K.S. Polonsky Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young N Engl J Med 345 2001 971 980
3. P. Froguel, M. Vaxillaire, and F. Sun Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus Nature 356 1992 162 164
4. F.M. Matschinsky, B. Glaser, and M.A. Magnuson Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities Diabetes 47 1998 307 315
5. G. Velho, K.F. Petersen, and G. Perseghin Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects J Clin Invest 98 1996 1755 1761
6. J. Jonsson, L. Carlsson, and T. Edlund Insulin-promoter-factor 1 is required for pancreas development in mice Nature 371 1994 606 609
7. D.A. Stoffers, N.T. Zinkin, and V. Stanojevic Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence Nat Genet 15 1997 106 110
8. F.J. Naya, C.M. Stellrecht, and M.J. Tsai Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor Genes Dev 9 1995 1009 1019
9. T.H. Lindner, P.R. Njolstad, and Y. Horikawa A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta Hum Mol Genet 8 1999 2001 2008
10. C. Bingham, M.P. Bulman, and S. Ellard Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease Am J Hum Genet 68 2001 219 224
11. I. Carbone, M. Cotellessa, and C. Barella A novel hepatocyte nuclear factor-1beta (MODY-5) gene mutation in an Italian family with renal dysfunctions and early-onset diabetes Diabetologia 45 2002 153 154
12. E.R. Pearson, W.G. Liddell, and M. Shepherd Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes Diabet Med 17 2000 543 545
13. K. Owen, and A.T. Hattersley Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization Best Pract Res Clin Endocrinol Metab 15 2001 309 323
14. E.R. Pearson, G. Velho, and P. Clark Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations Diabetes 50 Suppl 1 2001 S101 S107
15. M. Lehto, T. Tuomi, and M.M. Mahtani Characterization of the MODY3 phenotype: early-onset diabetes caused by an insulin secretion defect J Clin Invest 99 1997 582 591
16. K.E. von Muhlendahl, and H. Herkenhoff Long-term course of neonatal diabetes N Engl J Med 333 1995 704 708
17. I.K. Temple, R.J. Gardner, and D.J. Mackay Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes Diabetes 49 2000 1359 1366
18. I.K. Temple, and J.P. Shield Transient neonatal diabetes, a disorder of imprinting J Med Genet 39 2002 872 875
19. R.J. Gardner, D.J. Mackay, and A.J. Mungall An imprinted locus associated with transient neonatal diabetes mellitus Hum Mol Genet 9 2000 589 596
20. J.V. Sagen, H. Raeder, and E. Hathout Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy Diabetes 53 2004 2713 2718
21. A.L. Gloyn, E.R. Pearson, and J.F. Antcliff Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes N Engl J Med 350 2004 1838 1849
22. P. Thomas, Y. Ye, and E. Lightner Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy Hum Mol Genet 5 1996 1809 1812
23. P.R. Njolstad, O. Sovik, and A. Cuesta-Munoz Neonatal diabetes mellitus due to complete glucokinase deficiency N Engl J Med 344 2001 1588 1592
24. S. Brickwood, D.T. Bonthron, and L.I. Al-Gazali Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3 J Med Genet 40 2003 685 689
25. T.A. Chatila, F. Blaeser, and N. Ho JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome J Clin Invest 106 2000 R75 R81
26. E. Levy-Lahad, and R.S. Wildin Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: further evidence for an X-linked lethal syndrome J Pediatr 138 2001 577 580
27. J.E. Peake, R.B. McCrossin, and G. Byrne X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea Arch Dis Child Fetal Neonatal Ed 74 1996 F195 F199
28. O. Baud, O. Goulet, and D. Canioni Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation N Engl J Med 344 2001 1758 1762
29. T.G. Barrett, S.E. Bundey, and A.F. Macleod Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome Lancet 346 1995 1458 1463
30. R.G. Swift, D.B. Sadler, and M. Swift Psychiatric findings in Wolfram syndrome homozygotes Lancet 336 1990 667 669
31. R.G. Swift, M.H. Polymeropoulos, and R. Torres Predisposition of Wolfram syndrome heterozygotes to psychiatric illness Mol Psychiatry 3 1998 86 91
32. T. Ohata, A. Koizumi, and T. Kayo Evidence of an increased risk of hearing loss in heterozygous carriers in a Wolfram syndrome family Hum Genet 103 1998 470 474
33. B.T. Kinsley, M. Swift, and R.H. Dumont Morbidity and mortality in the Wolfram syndrome Diabetes Care 18 1995 1566 1570
34. H. Inoue, Y. Tanizawa, and J. Wasson A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) Nat Genet 20 1998 143 148
35. T.M. Strom, K. Hortnagel, and S. Hofmann Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein Hum Mol Genet 7 1998 2021 2028
36. H. El-Shanti, A.C. Lidral, and N. Jarrah Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q Am J Hum Genet 66 2000 1229 1236
37. F. Khanim, J. Kirk, and F. Latif WFS1/wolframin mutations, Wolfram syndrome, and associated diseases Hum Mutat 17 2001 357 367
38. J.M. van den Ouweland, H.H. Lemkes, and W. Ruitenbeek Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness Nat Genet 1 1992 368 371
39. P.J. Guillausseau, P. Massin, and D. Dubois-LaForgue Maternally inherited diabetes and deafness: a multicenter study Ann Intern Med 134 9 Pt 1 2001 721 728
40. M. Hirano, E. Ricci, and M.R. Koenigsberger Melas: an original case and clinical criteria for diagnosis Neuromuscul Disord 2 1992 125 135
41. A. Rotig, M. Colonna, and J.P. Bonnefont Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome Lancet 1 1989 902 903
42. A. Moran, D. Hardin, and D. Rodman Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report Diabetes Res Clin Pract 45 1999 61 73
43. A.D. Mackie, S.J. Thornton, and F.P. Edenborough Cystic fibrosis-related diabetes Diabet Med 20 2003 425 436
44. S.J. Hunter, and W.T. Garvey Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system Am J Med 105 1998 331 345
45. A. Krook, L. Brueton, and S. O'Rahilly Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism Lancet 342 1993 277 278
46. N. Longo, Y. Wang, and S.A. Smith Genotype-phenotype correlation in inherited severe insulin resistance Hum Mol Genet 11 2002 1465 1475
47. N. Longo, Y. Wang, and M. Pasquali Progressive decline in insulin levels in Rabson-Mendenhall syndrome J Clin Endocrinol Metab 84 1999 2623 2629
48. C. Musso, E. Cochran, and S.A. Moran Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective Medicine (Baltimore) 83 2004 209 222
49. E.A. Oral Lipoatrophic diabetes and other related syndromes Rev Endocr Metab Disord 4 2003 61 77
50. D. Jaquet, E. Khallouf, and C. Levy-Marchal Extremely low values of serum leptin in children with congenital generalized lipoatrophy Eur J Endocrinol 140 1999 107 109
51. J.M. Peters, R. Barnes, and L. Bennett Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22 Nat Genet 18 1998 292 295
52. H. Cao, and R.A. Hegele Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy Hum Mol Genet 9 2000 109 112
53. A. Garg, R.M. Peshock, and J.L. Fleckenstein Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety) J Clin Endocrinol Metab 84 1999 170 174
54. A. Garg Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety) J Clin Endocrinol Metab 85 2000 1776 1782